United Therapeutics (UTHR) Other Working Capital Changes (2016 - 2025)
United Therapeutics' Other Working Capital Changes history spans 17 years, with the latest figure at $98.2 million for Q4 2025.
- For Q4 2025, Other Working Capital Changes rose 463.7% year-over-year to $98.2 million; the TTM value through Dec 2025 reached $80.9 million, up 1051.76%, while the annual FY2025 figure was $80.9 million, 1051.76% up from the prior year.
- Other Working Capital Changes for Q4 2025 was $98.2 million at United Therapeutics, up from -$67.2 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $184.4 million in Q2 2025 and bottomed at -$134.5 million in Q1 2025.
- The 5-year median for Other Working Capital Changes is $7.2 million (2021), against an average of $17.7 million.
- The largest annual shift saw Other Working Capital Changes skyrocketed 648.41% in 2022 before it crashed 1086.05% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at $12.6 million in 2021, then surged by 648.41% to $94.3 million in 2022, then tumbled by 124.5% to -$23.1 million in 2023, then dropped by 16.88% to -$27.0 million in 2024, then skyrocketed by 463.7% to $98.2 million in 2025.
- Per Business Quant, the three most recent readings for UTHR's Other Working Capital Changes are $98.2 million (Q4 2025), -$67.2 million (Q3 2025), and $184.4 million (Q2 2025).